Title:
LIPID COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2024/032613
Kind Code:
A1
Abstract:
Provided is a drug delivery system suitable for tumor administration, which particularly relates to a lipid composition suitable for intratumoral administration. A therapeutic agent and/or a preventive the lipid composition comprises is RNA and suitable for intratumoral administration, and the lipid composition can be used to deliver the therapeutic agent and/or the preventive to a mammalian tumor so as to regulate and control the expression of a polypeptide, a protein or a gene.
Inventors:
HANG YU (CN)
HUANG LEI (CN)
SHEN HAIFA (CN)
LI HANGWEN (CN)
HUANG LEI (CN)
SHEN HAIFA (CN)
LI HANGWEN (CN)
Application Number:
PCT/CN2023/111750
Publication Date:
February 15, 2024
Filing Date:
August 08, 2023
Export Citation:
Assignee:
STEMIRNA THERAPEUTICS CO LTD (CN)
International Classes:
A61K9/00; A61K47/18; A61K9/127; A61P35/00; C07C227/08; C12N15/11
Foreign References:
| CN113015540A | 2021-06-22 | |||
| US20190167811A1 | 2019-06-06 | |||
| CN110520409A | 2019-11-29 |
Other References:
JIAYING MIAO ，, LU WEI: "Research Progress of Non-viral Vector Delivery System for mRNA Vaccine", PROGRESS IN PHARMACEUTICAL SCIENCES, vol. 46, no. 2, 25 February 2012 (2012-02-25), pages 84 - 92, XP093137179
Attorney, Agent or Firm:
HANGZHOU TIANHAO PATENT AGENCY CO., LTD. (CN)
Download PDF: